ETON

$0.00

(

+0.00%

)
Quote details

stock

Eton Pharmaceuticals Inc

NASDAQ | ETON

19.25

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 5, 2025)

$494.78M

Market Cap

-

P/E Ratio

-0.15

EPS

$23.00

52 Week High

$8.43

52 Week Low

HEALTHCARE

Sector

ETON Chart

Recent Chart
Price Action

ETON Technicals

Tags:

ETON Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $23M
Total Revenue $39M
Cost Of Revenue $16M
Costof Goods And Services Sold $16M
Operating Income -$2.6M
Selling General And Administrative $23M
Research And Development $3.3M
Operating Expenses $26M
Investment Income Net -
Net Interest Income -$1.2M
Interest Income -
Interest Expense $2M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.1M
Income Before Tax -$3.8M
Income Tax Expense $15K
Interest And Debt Expense -
Net Income From Continuing Operations -$3.8M
Comprehensive Income Net Of Tax -
Ebit -$2.6M
Ebitda -$1.5M
Net Income -$3.8M

Revenue & Profitability

Earnings Performance

ETON Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $76M
Total Current Assets $41M
Cash And Cash Equivalents At Carrying Value $15M
Cash And Short Term Investments $15M
Inventory $15M
Current Net Receivables $5.4M
Total Non Current Assets $35M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $35M
Intangible Assets Excluding Goodwill $35M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $5.5M
Other Non Current Assets -
Total Liabilities $52M
Total Current Liabilities $20M
Current Accounts Payable $4.2M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $32M
Capital Lease Obligations $107K
Long Term Debt $30M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $30M
Other Current Liabilities $16M
Other Non Current Liabilities $1.8M
Total Shareholder Equity $24M
Treasury Stock -
Retained Earnings -$108M
Common Stock $27K
Common Stock Shares Outstanding $26M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $969K
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.1M
Capital Expenditures $26K
Change In Receivables -
Change In Inventory -$1.3M
Profit Loss -
Cashflow From Investment -$40M
Cashflow From Financing $33M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$3.8M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $23M
Total Revenue $39M
Cost Of Revenue $16M
Costof Goods And Services Sold $16M
Operating Income -$2.6M
Selling General And Administrative $23M
Research And Development $3.3M
Operating Expenses $26M
Investment Income Net -
Net Interest Income -$1.2M
Interest Income -
Interest Expense $2M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.1M
Income Before Tax -$3.8M
Income Tax Expense $15K
Interest And Debt Expense -
Net Income From Continuing Operations -$3.8M
Comprehensive Income Net Of Tax -
Ebit -$2.6M
Ebitda -$1.5M
Net Income -$3.8M

ETON News

ETON Profile

Eton Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company based in Deer Park, Illinois, focused on developing and commercializing innovative therapies for patients with rare diseases. With a strong pipeline of proprietary products, Eton is committed to addressing significant unmet medical needs, thereby improving patient outcomes in niche markets. The company's emphasis on research and development, complemented by strategic partnerships, positions it as a pivotal entity in the pharmaceutical sector, capitalizing on opportunities in areas with limited competition.

CHR
-45.58%
$0.07
NVVE
-5.52%
$0.19
MTC
+409.86%
$1.55
ASST
+18.80%
$1.48
RIVN
+23.36%
$15.42
NVDA
-1.75%
$195.21
BYND
-4.31%
$1.33
LNAI
+45.09%
$1.21
VHAI
0.00%
$0.00
GPUS
+8.87%
$0.38
PFE
+1.37%
$24.63
RUBI
-49.75%
$0.30
SNAP
-2.00%
$7.32
PLUG
+4.76%
$2.64
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
SLDP
+51.55%
$8.51
YDKG
-5.55%
$0.05
ETHD
+20.91%
$5.26
F
+2.69%
$13.13
SMX
+38.80%
$2.04
PLTR
-1.48%
$187.90
T
-0.36%
$24.44
DNN
-2.18%
$2.68
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
PINS
-22.92%
$25.36
ACHR
+0.26%
$9.58
AAL
+6.08%
$13.42
BITF
+5.72%
$4.05
CMBM
+58.82%
$3.24
ONDS
+0.67%
$6.00
WTO
-0.20%
$0.04
CIFR
+9.77%
$24.71
SOFI
+2.38%
$30.07
SMCI
-11.11%
$42.13
TEVA
+20.16%
$24.58
INTC
+3.96%
$38.50
BAC
-2.04%
$52.44
AMZN
-1.84%
$249.32
KVUE
+1.94%
$16.28
ADAP
-15.14%
$0.05
NFE
+13.99%
$1.53
AMCR
+3.04%
$8.11
BTG
+1.12%
$4.04
IREN
-1.65%
$66.63
MARA
+3.06%
$17.13
RXRX
-8.08%
$5.00
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
RIG
-0.12%
$3.89
U
+18.12%
$42.37
RGTI
+5.99%
$37.29
RMBL
+60.50%
$3.21
JOBY
-9.55%
$14.76
FUBO
+11.00%
$4.08
ADD
-25.47%
$0.05
WBD
+0.53%
$22.71
BURU
-2.17%
$0.28
NVO
+0.43%
$48.46
QS
+9.93%
$16.97
WULF
+2.46%
$15.38
CAN
+14.43%
$1.27
BTBT
+3.14%
$3.28
EPWK
-7.75%
$0.06
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
BMNR
+4.89%
$41.39
NCLH
-0.95%
$18.61
RIOT
-1.58%
$18.97
ZDAI
+13.94%
$0.52
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
CMG
+0.72%
$31.97
APPS
+23.14%
$7.29
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
QBTS
+4.37%
$31.04
KDLY
-11.88%
$0.78
NGD
+2.48%
$6.80
GOOGL
+2.43%
$284.31
NIO
+2.30%
$7.32
BBD
+3.37%
$3.52
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
CGC
-5.83%
$1.12
HPE
+0.59%
$23.70
PCG
+1.05%
$16.32
AG
-7.82%
$10.65
PLTZ
+2.80%
$6.24
GGB
+5.11%
$3.59
ETWO
0.00%
$3.30
HBAN
+0.13%
$15.29
HOOD
-6.98%
$136.80
ITUB
+1.55%
$7.49
MSPR
-27.89%
$0.47
AAPL
-0.18%
$269.53
IONZ
-7.18%
$4.14
SOUN
+2.36%
$15.48
CHR
-45.58%
$0.07
NVVE
-5.52%
$0.19
MTC
+409.86%
$1.55
ASST
+18.80%
$1.48
RIVN
+23.36%
$15.42
NVDA
-1.75%
$195.21
BYND
-4.31%
$1.33
LNAI
+45.09%
$1.21
VHAI
0.00%
$0.00
GPUS
+8.87%
$0.38
PFE
+1.37%
$24.63
RUBI
-49.75%
$0.30
SNAP
-2.00%
$7.32
PLUG
+4.76%
$2.64
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
SLDP
+51.55%
$8.51
YDKG
-5.55%
$0.05
ETHD
+20.91%
$5.26
F
+2.69%
$13.13
SMX
+38.80%
$2.04
PLTR
-1.48%
$187.90
T
-0.36%
$24.44
DNN
-2.18%
$2.68
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
PINS
-22.92%
$25.36
ACHR
+0.26%
$9.58
AAL
+6.08%
$13.42
BITF
+5.72%
$4.05
CMBM
+58.82%
$3.24
ONDS
+0.67%
$6.00
WTO
-0.20%
$0.04
CIFR
+9.77%
$24.71
SOFI
+2.38%
$30.07
SMCI
-11.11%
$42.13
TEVA
+20.16%
$24.58
INTC
+3.96%
$38.50
BAC
-2.04%
$52.44
AMZN
-1.84%
$249.32
KVUE
+1.94%
$16.28
ADAP
-15.14%
$0.05
NFE
+13.99%
$1.53
AMCR
+3.04%
$8.11
BTG
+1.12%
$4.04
IREN
-1.65%
$66.63
MARA
+3.06%
$17.13
RXRX
-8.08%
$5.00
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
RIG
-0.12%
$3.89
U
+18.12%
$42.37
RGTI
+5.99%
$37.29
RMBL
+60.50%
$3.21
JOBY
-9.55%
$14.76
FUBO
+11.00%
$4.08
ADD
-25.47%
$0.05
WBD
+0.53%
$22.71
BURU
-2.17%
$0.28
NVO
+0.43%
$48.46
QS
+9.93%
$16.97
WULF
+2.46%
$15.38
CAN
+14.43%
$1.27
BTBT
+3.14%
$3.28
EPWK
-7.75%
$0.06
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
BMNR
+4.89%
$41.39
NCLH
-0.95%
$18.61
RIOT
-1.58%
$18.97
ZDAI
+13.94%
$0.52
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
CMG
+0.72%
$31.97
APPS
+23.14%
$7.29
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
QBTS
+4.37%
$31.04
KDLY
-11.88%
$0.78
NGD
+2.48%
$6.80
GOOGL
+2.43%
$284.31
NIO
+2.30%
$7.32
BBD
+3.37%
$3.52
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
CGC
-5.83%
$1.12
HPE
+0.59%
$23.70
PCG
+1.05%
$16.32
AG
-7.82%
$10.65
PLTZ
+2.80%
$6.24
GGB
+5.11%
$3.59
ETWO
0.00%
$3.30
HBAN
+0.13%
$15.29
HOOD
-6.98%
$136.80
ITUB
+1.55%
$7.49
MSPR
-27.89%
$0.47
AAPL
-0.18%
$269.53
IONZ
-7.18%
$4.14
SOUN
+2.36%
$15.48

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.